Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
Titel:
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
Auteur:
Boonen, Steven Lorenc, Roman S. Wenderoth, Dietrich Stoner, Karen J. Eusebio, Rachelle Orwoll, Eric S.